Did you know cervical cancer is the 10th most common cancer and the 8th most common cause of cancer death among Singaporean women? Almost all cervical cancers are linked to HPV infections. Take control of your reproductive health with Camtech Health's HPV Self-Sampling Test Kit, designed for convenient, accurate, and discreet at-home testing. This easy-to-use kit empowers you with a simple self-sampling process and delivers secure, fast results via the Camtech Health app. Features: Simple and easy-to-use: Step-by-step instructions for hassle-free sample collection HSA-approved: Approved by the Health Sciences Authority and compliant with MOH guidelines. Accurate and reliable: The same test used in Denmark’s national HPV screening program, ensuring high sensitivity and specificity. Secure digital results: Results are available through the Camtech Health app, with follow-up options for positive cases. No appointment needed: Skip the clinic and avoid uncomfortable procedures. Less invasive than Pap Smears: The soft, small swab tip ensures a painless collection process, unlike Pap smears which can be more uncomfortable. Who is it for? Ideal for women who want to stay proactive about their health. Regular HPV testing is recommended even if you're symptom-free. What’s included: Easy-to-follow instructions HPV Self-Sampling Swab (FLOQSwab) Patient Label for identification Specimen Bag for safe sample storage Pre-paid return envelope for easy mailing to the lab Stay empowered with early detection. Camtech Health HPV Test not only screens for high-risk HPV 16/18 but also extended genotypes of clinical significance. Knowing which HPV genotype means your doctor can better decide the next steps in your health care. How it works 1. Order and receive the self-sampling collection kit at your home2. Complete a short medical assessment after purchase3. Follow the instructions provided in the kit to collect your sample. 4. Return the sample to Camtech Health for processing.5. Your results will be available on the Camtech Health App within 1-2 weeks. Frequently Asked Questions (FAQs) 1. What is HPV?Human Papillomavirus (HPV) is a group of common viruses that cause infections in both men and women. Most HPV infections clear up on their own, however, persistent infection by certain HPV types can cause cervical cancer in women over time. The link between HPV and cervical cancer makes it highly preventable through HPV vaccination and regular HPV screening. 2. Who is suitable to take the HPV Test? It is currently recommended that women aged 30 and above who have previously engaged in sexual intercourse should go for regular cervical cancer screening. Screening frequency is once every 5 years. 3. I have taken my HPV vaccination, do I still need to go for regular cervical cancer screening? While the HPV vaccine protects against some types of HPV, it doesn't protect against them all—and no vaccine is 100% effective. The HPV vaccine also would not have treated any existing HPV infections. This means that regular cervical screening remains important. 4. How easy is it to collect my own sample? Sample collection should be quick, easy and done in the comfort of your home. You can refer to this link here for an instructional video on how to collect your sample. 5. When is the best time to do the self-sampling?It’s best to perform the self-sampling when you are not on your period and in a private, comfortable setting. The self-sampling can be done at any time within the entire day. 6. When should I not use the test? Please wait at least 48 hours after intercourse/sexual activity or using vaginal creams, gels or tablets before collecting your sample. In addition, this testing is not suitable for use during pregnancy. If you are pregnant and have concerns about HPV, please talk to your doctor. 7. What happens if I am HPV positive? With HPV extended genotyping, doctors are better equipped to know whether their patients have a type of HPV that puts them at high risk of cervical cancer and can better discuss next steps in their health care. Those steps might include follow-up monitoring, further testing, or treatment of abnormal or precancerous cells.
